Company

Phylo, Inc.

Phylo develops AI bioinformatics tools for biological research.

About

Founded in 2025 and based in South San Francisco, US, Phylo develops Biomni Lab, a collaborative platform for tasks including protein design, multi-omics analysis and literature synthesis. It serves academic institutions, biotechnology firms and research organizations. In February 2026, it raised USD 13.5 mn in Seed funding co-led by Andreessen Horowitz and Menlo Ventures, with participation from Zetta Venture Partners, Conviction and SV Angel.

1Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in